NCT07277491

Brief Summary

The aim of the present work is to assess the nutritional status among different rheumatic diseases patients and to study its association with the corresponding diseases activity.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
460

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

September 5, 2025

Completed
3 months until next milestone

First Posted

Study publicly available on registry

December 11, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2026

Completed
Last Updated

March 9, 2026

Status Verified

March 1, 2026

Enrollment Period

3.2 years

First QC Date

September 5, 2025

Last Update Submit

March 6, 2026

Conditions

Keywords

nutritional statusrheumatic diseasesdisease activity

Outcome Measures

Primary Outcomes (4)

  • Nutritional Status as Assessed by the Prognostic Nutritional Index (PNI)

    The Prognostic Nutritional Index (PNI) is an index score calculated using the formula: Serum Albumin (g/L) + 5 Ă— Total Lymphocyte Count (/mm³). Unit of Measure: Calculated Index Score Interpretation: Higher scores indicate better nutritional status

    Assessed during routine clinic visits between January 1, 2023, and December 30, 2025.

  • Nutritional Risk as Assessed by the Nutritional Risk Index (NRI)

    The Nutritional Risk Index (NRI) is an index score calculated based on serum albumin levels and the percentage of weight loss. Unit of Measure: Calculated Index Score Interpretation: Higher scores indicate a lower nutritional risk

    Assessed during routine clinic visits between January 1, 2023, and December 30, 2025.

  • Nutritional Status as Assessed by the Subjective Global Assessment (SGA)

    The Subjective Global Assessment (SGA) is a clinical tool that results in a score based on a patient questionnaire and physical examination. Unit of Measure: Score on a 7-point scale Interpretation: Higher scores indicate better nutritional status.

    Assessed during routine clinic visits between January 1, 2023, and December 30, 2025.

  • Nutritional Status as Assessed by the Mini Nutritional Assessment - Short Form (MNA-SF)

    The Mini Nutritional Assessment - Short Form (MNA-SF) is a screening tool consisting of a questionnaire administered to the patient. Unit of Measure: Score on a 14-point scale Interpretation: Scores are categorized as: 12-14 (normal nutritional status), 8-11 (at risk of malnutrition), or 0-7 (malnourished).

    Assessed during routine clinic visits between January 1, 2023, and December 30, 2025

Secondary Outcomes (5)

  • corrolation between Body Mass Index (BMI) and disease activity

    Assessed during routine clinic visits between January 1, 2023, and December 30, 2025

  • corrolation between Prognostic Nutritional Index (PNI) and disease activity

    Assessed during routine clinic visits between January 1, 2023, and December 30, 2025.

  • corrolation between Nutritional Risk Index (NRI) and disease activity

    Assessed during routine clinic visits between January 1, 2023, and December 30, 2025.

  • Corrolation between Nutritional Status Categorization by Subjective Global Assessment (SGA) and disease activity

    Assessed during routine clinic visits between January 1, 2023, and December 30, 2025.

  • Duration of Rheumatic Disease

    Assessed during routine clinic visits between January 1, 2023, and December 30, 2025.

Study Arms (2)

cases with different rheumatic diseases

135 patients with different rheumatic diseases who attended the outpatient Rheumatology Clinic, Cairo University Hospitals as well as the Health Insurance Hospital, Aswan Governorate Patients diagnosed with rheumatic diseases including RA,SpA,SLE and SSc were included

control cases matched for age and sex

control cases selected from healthy volunteers matched for age and sex

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Population of study: Patients of both genders were recruited in this study. Study subjects were patients with different rheumatic diseases attending the outpatient Rheumatology Clinic. Patients who visited the clinic from January 2023 to December 2025 were asked to participate after being provided with an explanation of the work. Study location: Study was conducted in the outpatient clinics of the Rheumatology Department, Cairo University Hospitals as well as in the Health Insurance Hospital, Aswan Governorate.

You may qualify if:

  • Patients diagnosed with rheumatic diseases including RA, SpA, SLE and SSc.

You may not qualify if:

  • Patients who are unable to comply with the physician assessment.
  • Patients with other connective tissue diseases, neurological diseases, malignancy, heart failure or severe renal dysfunction was excluded, as these diseases affect the muscle mass causing sarcopenia.
  • Advanced liver diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department: Rheumatology and Rehabilitation Department, Faculty of Medicine, Cairo University

Cairo, 12613, Egypt

RECRUITING

Related Publications (10)

  • Liu H, Jiao J, Zhu M, Wen X, Jin J, Wang H, Lv D, Zhao S, Sun X, Wu X, Xu T. Nutritional Status According to the Short-Form Mini Nutritional Assessment (MNA-SF) and Clinical Characteristics as Predictors of Length of Stay, Mortality, and Readmissions Among Older Inpatients in China: A National Study. Front Nutr. 2022 Jan 25;9:815578. doi: 10.3389/fnut.2022.815578. eCollection 2022.

    PMID: 35145987BACKGROUND
  • Olsen MN, Tangvik RJ, Halse AK. Evaluation of Nutritional Status and Methods to Identify Nutritional Risk in Rheumatoid Arthritis and Spondyloarthritis. Nutrients. 2020 Nov 21;12(11):3571. doi: 10.3390/nu12113571.

    PMID: 33233336BACKGROUND
  • Malone A, Mogensen KM. Key approaches to diagnosing malnutrition in adults. Nutr Clin Pract. 2022 Feb;37(1):23-34. doi: 10.1002/ncp.10810. Epub 2021 Dec 22.

    PMID: 34936131BACKGROUND
  • Klak A, Borowicz J, Manczak M, Grygielska J, Samel-Kowalik P, Raciborski F. Current nutritional status of patients with rheumatic diseases in the population of Poland. Reumatologia. 2015;53(1):26-33. doi: 10.5114/reum.2015.50554. Epub 2015 Apr 10.

    PMID: 27407222BACKGROUND
  • Vellas B, Guigoz Y, Garry PJ, Nourhashemi F, Bennahum D, Lauque S, Albarede JL. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition. 1999 Feb;15(2):116-22. doi: 10.1016/s0899-9007(98)00171-3.

    PMID: 9990575BACKGROUND
  • Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, Mendelson RA, Jeejeebhoy KN. What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr. 1987 Jan-Feb;11(1):8-13. doi: 10.1177/014860718701100108.

    PMID: 3820522BACKGROUND
  • Alwall N. Historical perspective on the development of the artificial kidney. Artif Organs. 1986 Apr;10(2):86-99. doi: 10.1111/j.1525-1594.1986.tb02526.x. No abstract available.

    PMID: 3521553BACKGROUND
  • Correa-Rodriguez M, Pocovi-Gerardino G, Callejas-Rubio JL, Fernandez RR, Martin-Amada M, Cruz-Caparros MG, Ortego-Centeno N, Rueda-Medina B. The Prognostic Nutritional Index and Nutritional Risk Index Are Associated with Disease Activity in Patients with Systemic Lupus Erythematosus. Nutrients. 2019 Mar 16;11(3):638. doi: 10.3390/nu11030638.

    PMID: 30884776BACKGROUND
  • Aparicio-Soto M, Sanchez-Hidalgo M, Alarcon-de-la-Lastra C. An update on diet and nutritional factors in systemic lupus erythematosus management. Nutr Res Rev. 2017 Jun;30(1):118-137. doi: 10.1017/S0954422417000026. Epub 2017 Mar 15.

    PMID: 28294088BACKGROUND
  • Allanore Y, Simms R, Distler O, Trojanowska M, Pope J, Denton CP, Varga J. Systemic sclerosis. Nat Rev Dis Primers. 2015 Apr 23;1:15002. doi: 10.1038/nrdp.2015.2.

    PMID: 27189141BACKGROUND

MeSH Terms

Conditions

SpondylarthritisArthritis, PsoriaticScleroderma, SystemicArthritis, RheumatoidRheumatic Diseases

Condition Hierarchy (Ancestors)

SpondylitisSpinal DiseasesBone DiseasesMusculoskeletal DiseasesArthritisJoint DiseasesSpondylarthropathiesPsoriasisSkin Diseases, PapulosquamousSkin DiseasesSkin and Connective Tissue DiseasesConnective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Dina Ossama Abdulazim, assistant professor

    Rheumatology and Rehabilitation Department, Faculty of Medicine, Cairo University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Reem Mahmoud Lotfy, Rheumatology Specialist

CONTACT

Tamer Atef Gheita, Professor of rheumatology

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Target Duration
5 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Rheumatology Specialist

Study Record Dates

First Submitted

September 5, 2025

First Posted

December 11, 2025

Study Start

January 1, 2023

Primary Completion

February 28, 2026

Study Completion

February 28, 2026

Last Updated

March 9, 2026

Record last verified: 2026-03

Locations